E-cigarettes: The lingering questions

Daniel Cressey in Nature:

Cig1In many respects, the modern electronic cigarette is not so different from its leaf-and-paper predecessor. Take a drag from the mouthpiece and you get a genuine nicotine fix — albeit from a fluid wicked into the chamber of a battery-powered atomizer and vaporized by a heating element. Users exhale a half-convincing cloud of ‘smoke’, and many e-cigarettes even sport an LED at the tip that glows blue, green or classic red to better simulate the experience romanticized by countless writers and film-makers. The only things missing are the dozens of cancer-causing chemicals found in this digital wonder’s analogue forebears.

E-cigarettes — also known as personal vaporizers or electronic nicotine-delivery systems among other names — are perhaps the most disruptive devices that public-health researchers working on tobacco control have ever faced. To some, they promise to snuff out a behaviour responsible for around 100 million deaths in the twentieth century. Others fear that they could perpetuate the habit, and undo decades of work. Now, a group once united against a common enemy is divided. “These devices have really polarized the tobacco-control community,” says Michael Siegel, a physician and tobacco researcher at Boston University School of Public Health in Massachusetts. “You now have two completely opposite extremes with almost no common ground between them.” Evidence is in short supply on both sides. Even when studies do appear, they are often furiously debated. And it is not just researchers who are attempting to catch up with the products now pouring out of Chinese factories: conventional tobacco companies are pushing into the nascent industry, and regulators are scrambling to work out what to do.

More here.